bicalutamide 50 MG Oral Tablet [Casodex]
bicalutamide
RxCUI: 108828
What the CMS Formulary Data Shows for bicalutamide 50 MG Oral Tablet [Casodex]
Per the CMS 2026 Part D formulary file, bicalutamide 50 MG Oral Tablet [Casodex] (RxNorm concept RXCUI 108828, generic name bicalutamide) appears on 1 distinct formulary file spanning 2 Medicare Part D plan offerings - 0% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 1, with a cross-plan average of Tier 1.
Real-world access to bicalutamide 50 MG Oral Tablet [Casodex] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 73,843 Part D beneficiaries filled bicalutamide 50 MG Oral Tablet [Casodex] in 2023, with total plan-and-beneficiary spending of $7,496,334 and an average per-beneficiary annual cost of $101.52. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry bicalutamide 50 MG Oral Tablet [Casodex] today.
Coverage Details
- Formularies covering
- 1
- Plans covering
- 2
- Coverage rate
- 0%
- Tier range
- Tier 1, Preferred Generic
- Average tier
- Tier 1, Preferred Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 73,843
- Total spending
- $7,496,334
- Avg per beneficiary
- $101.52
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering bicalutamide 50 MG Oral Tablet [Casodex]
2 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Hamaspik Medicare Choice (HMO D-SNP) | HAMASPIK, INC. | T1 | No | $0 | NY |
| Hamaspik Medicare Select (HMO D-SNP) | HAMASPIK, INC. | T1 | No | $34.50 | NY |
Frequently Asked Questions
Is bicalutamide 50 MG Oral Tablet [Casodex] covered by Medicare Part D?
Yes, bicalutamide 50 MG Oral Tablet [Casodex] is covered by 2 Medicare Part D plans (0% of all Part D formularies).
What tier is bicalutamide 50 MG Oral Tablet [Casodex] on Medicare Part D plans?
bicalutamide 50 MG Oral Tablet [Casodex] averages Tier 1 across Part D plans, ranging from Tier 1 to Tier 1.
Does bicalutamide 50 MG Oral Tablet [Casodex] require prior authorization?
0% of Part D formularies require prior authorization for bicalutamide 50 MG Oral Tablet [Casodex]. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on bicalutamide 50 MG Oral Tablet [Casodex]?
In 2023, total Medicare Part D spending on bicalutamide 50 MG Oral Tablet [Casodex] was $7,496,334, covering 73,843 beneficiaries. The average spend per beneficiary was $101.52.
Read our methodology - how this data is sourced, computed, and verified.